Mirum Pharmaceuticals, Inc. (MIRM): Total Liabilities
$528.12M
As of 2025-12-31
$1.06B
As of 2026-06-30
+35.8%
3-year compound annual growth
+50.3%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $528.12M | +18.6% | 2026-02-25, Balance as of period end |
| 2024-12-31 | $445.11M | +11.9% | 2026-02-25, Balance as of period end |
| 2023-12-31 | $397.95M | +88.7% | 2025-02-26, Balance as of period end |
| 2022-12-31 | $210.87M | +20.9% | 2024-03-15, Balance as of period end |
| 2021-12-31 | $174.44M | +153.7% | 2023-03-08, Balance as of period end |
| 2020-12-31 | $68.77M | +320.3% | 2022-03-09, Balance as of period end |
| 2019-12-31 | $16.36M | +568.2% | 2021-03-09, Balance as of period end |
| 2018-12-31 | $2.45M | n/a | 2020-03-12, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | 2025-12-31 | $528.12M | +18.6% |
| BridgeBio Pharma, Inc. (BBIO) | 2025-12-31 | $3.01B | +26.7% |
| HUTCHMED (China) Ltd (HCM) | 2025-12-31 | $501.83M | -0.1% |
| Travere Therapeutics, Inc. (TVTX) | 2025-12-31 | $490.36M | -8.4% |
| Organogenesis Holdings Inc. (ORGO) | 2025-12-31 | $164.81M | +46.4% |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $99.59M | +24.7% |
| Zai Lab Ltd (ZLAB) | 2025-12-31 | $456.88M | +32.5% |
| Insmed Inc (INSM) | 2025-12-31 | $1.53B | -12.3% |
| Opko Health, Inc. (OPK) | 2025-12-31 | $663.99M | -20.5% |
Compare MIRM, BBIO, HCM, TVTX side by side · Screen every company in Pharmaceutical Preparations ↗